Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,886.00p on 23-09-2026 at 18:25:09
Change -20.00p -1.05%
Buy 1,892.00p
Sell 1,891.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 1.00 at 1,886.00p
Day's Volume: 6,310,501
Last Close: 1,886.00p
Open: 1,895.50p
ISIN: GB00BN7SWP63
Day's Range 1,874.50p - 1,912.50p
52wk Range: 1,455.00p - 2,282.00p
Market Capitalisation: £75.57b
VWAP: 1,891.58197p
Shares in Issue: 4.01b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Higher Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 1 1,886.00p Automatic Execution
 16:36:35 - 23-Sep-26
Sell* 712 1,886.00p Automatic Execution
 16:36:26 - 23-Sep-26
Sell* 600 1,886.00p Automatic Execution
 16:36:14 - 23-Sep-26
Sell* 1,083 1,886.00p Automatic Execution
 16:36:14 - 23-Sep-26
Sell* 941 1,886.00p Automatic Execution
 16:36:14 - 23-Sep-26
Sell* 664 1,886.00p Automatic Execution
 16:36:14 - 23-Sep-26
Sell* 537 1,886.00p Automatic Execution
 16:36:14 - 23-Sep-26
Sell* 1,201 1,886.00p Automatic Execution
 16:36:14 - 23-Sep-26
Sell* 1,962 1,886.00p Automatic Execution
 16:36:14 - 23-Sep-26
Sell* 300 1,886.00p Automatic Execution
 16:36:13 - 23-Sep-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
22nd Sep 2026 (Tue) 1,913.50 1,913.50 1,881.00 1,906.00 5,135,262
21st Sep 2026 (Mon) 1,878.00 1,916.00 1,868.50 1,911.00 6,861,145
18th Sep 2026 (Fri) 1,907.00 1,912.00 1,852.50 1,877.50 15,668,260
17th Sep 2026 (Thu) 1,885.50 1,906.50 1,872.00 1,900.00 9,893,739
16th Sep 2026 (Wed) 1,855.50 1,883.50 1,853.50 1,865.50 7,165,366
15th Sep 2026 (Tue) 1,862.50 1,876.50 1,839.00 1,854.00 4,901,615
14th Sep 2026 (Mon) 1,800.00 1,870.00 1,789.50 1,854.50 4,365,126
11th Sep 2026 (Fri) 1,786.00 1,804.00 1,770.00 1,770.50 3,933,904
10th Sep 2026 (Thu) 1,800.00 1,803.50 1,775.50 1,775.50 3,018,164
9th Sep 2026 (Wed) 1,776.00 1,812.50 1,772.00 1,803.50 3,659,124
8th Sep 2026 (Tue) 1,824.00 1,829.50 1,782.00 1,796.50 5,349,814
7th Sep 2026 (Mon) 1,834.50 1,849.00 1,825.50 1,837.50 4,622,327
4th Sep 2026 (Fri) 1,866.00 1,869.00 1,835.50 1,846.50 3,782,286
3rd Sep 2026 (Thu) 1,871.00 1,911.00 1,858.50 1,866.50 4,089,291
2nd Sep 2026 (Wed) 1,874.00 1,889.50 1,851.00 1,861.50 4,977,182
1st Sep 2026 (Tue) 1,847.50 1,892.00 1,842.00 1,871.50 4,718,988
31st Aug 2026 (Mon) 1,853.50 1,853.50 1,853.50 1,853.50 0
28th Aug 2026 (Fri) 1,862.50 1,863.00 1,839.50 1,853.50 7,789,320
27th Aug 2026 (Thu) 1,890.00 1,902.00 1,852.00 1,852.00 3,594,159
26th Aug 2026 (Wed) 1,914.00 1,919.00 1,891.00 1,899.50 3,465,884
25th Aug 2026 (Tue) 1,900.50 1,912.00 1,868.50 1,905.50 4,599,109
24th Aug 2026 (Mon) 1,917.00 1,921.50 1,882.00 1,890.50 5,274,882
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
22nd Sep 2026 3:30 pm RNS Director/PDMR Shareholding
15th Sep 2026 7:00 am RNS GSK to acquire T cell-engager for multiple myeloma
14th Sep 2026 7:00 am RNS Ris-Rez Positive Ph 3 OS Lung Cancer Data in China
14th Sep 2026 7:00 am RNS Jideytro positive data for ROS1-positive NSCLC
11th Sep 2026 3:30 pm RNS Director/PDMR Shareholding
10th Sep 2026 3:30 pm RNS Director/PDMR Shareholding
10th Sep 2026 7:00 am RNS Japan approval of Shingrix in a prefilled syringe
9th Sep 2026 3:30 pm RNS Director/PDMR Shareholding
9th Sep 2026 3:30 pm RNS Director/PDMR Shareholding
1st Sep 2026 3:00 pm RNS Total Voting Rights
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

Vault Ventures rebrands as Sentry 7, appoints new CEO

21st Sep 2026 12:19

(Alliance News) - Vault Ventures PLC on Monday announced a change of name and leadership as it moves towards bringing its first product to the market. Read More

LONDON BRIEFING: UK inflation rises; Barratt cuts completions outlook

16th Sep 2026 07:59

(Alliance News) - UK inflation accelerates to 3.1% in August as higher fuel costs drive prices higher. Barratt Redrow reports a rise in annual pretax profit but lowers its home completions guidance, while Babcock says trading is in line with expectations and leaves its outlook unchanged. Read More

LONDON BROKER RATINGS: Berenberg likes GSK; Deutsche Bank lifts Astra

15th Sep 2026 09:53

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

GSK agrees up to USD750 million deal for blood cancer-targeting drug

15th Sep 2026 09:34

(Alliance News) - GSK PLC on Tuesday said it has agreed to buy "a potential best-in-class" T cell-engager aimed at treating multiple myeloma from China-based clinical-stage biotechnology company Chimagen Biosciences for up to USD750 million. Read More

LONDON BRIEFING: GSK in T-cell deal; Kier puts brakes on Property arm

15th Sep 2026 07:58

(Alliance News) - GSK says it has struck a deal to acquire a promising T-cell asset, while Kier Group's annual profit beat consensus. Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,705.26
Change-3.07

Login to your account

Forgot Password?

Not Registered